Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL)

Highlights • Female sexual dysfunction and quality of life are both multidimensional and have a bidirectional relationship across the reproductive life span and beyond. • Methodological difficulties exist in estimating the real prevalence of female sexual dysfunction in epidemiological studies, main...

Full description

Saved in:
Bibliographic Details
Published in:Maturitas 2016-12, Vol.94, p.87-91
Main Authors: Nappi, Prof. Rossella E., MD, PhD, Cucinella, Laura, Martella, Silvia, Rossi, Margherita, Tiranini, Lara, Martini, Ellis
Format: Article
Language:English
Subjects:
Distress
Female
Female sexual dysfunction
Humans
Hypoactive sexual desire disorder
Internal Medicine
Menopause - psychology
Middle Aged
Obstetrics and Gynecology
Prevalence
Quality of life
Quality of Life - psychology
Sexual Behavior - psychology
Sexual Dysfunctions, Psychological - diagnosis
Sexual Dysfunctions, Psychological - epidemiology
Sexual Dysfunctions, Psychological - psychology
Vulvovaginal atrophy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Female sexual dysfunction and quality of life are both multidimensional and have a bidirectional relationship across the reproductive life span and beyond. • Methodological difficulties exist in estimating the real prevalence of female sexual dysfunction in epidemiological studies, mainly because it is hard to determine the level of distress associated with sexual symptoms. • Approximately 40–50% women, irrespective of age, report at least one sexual symptom. • Some conditions related to hormonal changes at menopause, such as vulvovaginal atrophy and hypoactive sexual desire disorder, have a significant impact on sexual function and quality of life. • Health care providers should proactively address sexual symptoms at midlife and in older women. Adequate counselling and tailored hormonal and non-hormonal therapies may be useful to relieve symptoms.
ISSN:0378-5122
1873-4111
DOI:10.1016/j.maturitas.2016.09.013